Work

Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options

Year: 2013

Type: review

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2013.03.018

Authors: Elias J. Jabbour, Jorge E. Cortes, Hagop M. Kantarjian

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, Novartis, Teva Pharmaceutical Industries, Ariad Pharmaceuticals, National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W2064888584

FWCI: 1.473

Cites: 174

Cited by: 106

Related to: 10